|
Biologicals |
|
In the United States, Biologics are subject to licensure under
the Public Health Service Act. A biologic product is any virus,
therapeutic serum, toxin, antitoxin, vaccine, blood, blood
component or derivative, allergenic product, or analogous
product, applicable to the prevention, treatment or cure of
diseases or injuries to humans. Biological products include,
but are not limited to, bacterial and viral vaccines, human
blood and plasma and their derivatives, and certain products
produced by biotechnology, such as interferons and erythropoietins.
The FDA regulates Biologics through it's Center for Biologics
Evaluation and Research (CBER). FDA's Center for Biologics
Evaluation and Research CBER is responsible for ensuring:
the safety of this nation's entire blood supply and the products
derived from it; the production and approval of safe and effective
childhood vaccines, including any future AIDS vaccines; the
proper oversight of human tissue for transplantation; an adequate
and safe supply of allergenic materials and anti-toxins; the
safety and efficacy of biological therapeutics, including
an exciting new array of biotechnology-derived products used
to treat diseases such as cancer and AIDS. . :
The PHS Act requires individuals or companies who manufacture
biologics for introduction into interstate commerce to hold
a license for the products. These licenses are issued by FDA's
Center for Biologics Evaluation and Research (CBER). Biological
products intended for veterinary use are regulated under a
separate law, the Virus, Serum, and Toxin Act, which is administered
by the U.S. Department of Agriculture. Manufacturers of those
products are now required to submit only a biologics license
application (BLA),
Educational, Training, and Informational Resources |
|
|
|
|
|
|
|
|
For more information or assistance with your USFDA GMP, GLP, GCP, QSR, QSIT, Pre-Approval, or Foreign pharmaceutical, medical device, biologics, food, cosmetics, or nutraceutical inspections , please contact Global Regulatory.com at 403-770-1994, email us or Submit Regulatory Requests
Pharmaceuticals,
Biologicals,
Combination Products, Medical
Devices, Cosmetics, Animal Drug, Clinical Trial,
Food & Dietary Supplements
Please
visit our other websites:
|
|
US FDA Biological Related News |
|
Press Release
2006-08-02 00:00:00
The Food and Drug Administration (FDA) announced today that it has approved...
Press Release
2006-06-30 00:00:00
The Food and Drug Administration (FDA) today approved Lucentis (ranibizumab...
Press Release
2006-06-29 00:00:00
The Food and Drug Administration (FDA) granted accelerated approval for Spr...
Press Release
2006-06-29 00:00:00
The U.S. Food and Drug Administration (FDA) today announced that Baxter Hea...
Press Release
2006-06-08 00:00:00
The Food and Drug Administration (FDA) today announced the approval of Gard...
Press Release
2006-05-26 00:00:00
The Food and Drug Administration (FDA) licensed Zostavax, on May 25, 2006, ...
Press Release
2006-05-26 00:00:00
The Food and Drug Administration (FDA) licensed Zostavax, on May 25, 2006, ...
|
|
|